Intellia Therapeutics Inc (NTLA)

Investing Cash Flow

-$141.57M

Quarterly · Period ending: · USD

NTLA logo

NTLA Investing Cash Flow

Latest reported-$141.57M
NTLA Quarterly Cash from Investing ($0.00 → -$141.57M)
High-resolution chart · PNG

NTLA investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-141,572,000
66,310,000
27,534,000
-741,000
106,910,000
94,328,000
151,565,000
-7,709,000
-24,190,000
5,901,000
45,939,000
79,500,000
-34,538,000
-122,248,000
-30,152,000
47,643,000
95,345,000
47,473,000
-159,115,000
-399,381,000
33,260,000
-25,542,000
-210,918,000
-153,980,000
92,963,000
57,448,000
27,884,000
-31,652,000
23,249,000
5,695,000
-256,016,000
-2,016,000
-900,000
-1,850,000
-2,397,000
-2,260,000
-1,272,000
-4,162,000
-3,405,000
-605,000
-1,147,000
-1,008,000
-849,000
-602,000
-587,000
-516,000
-742,500
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.